Navigation Links
Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines(R)
Date:6/4/2009

Evidence-Based Care Guidelines will be used to Combat Waste in Medicare Programs

SEATTLE, June 4 /PRNewswire/ -- Connolly Healthcare, a permanent Recovery Audit Contractor (RAC) for the Centers for Medicare & Medicaid Services (CMS), has signed a five-year license agreement with Milliman Care Guidelines.

Connolly will use the Care Guidelines content and software to review Medicare claims in 15 states -- West Virginia, Virginia, North Carolina, South Carolina, Georgia, Florida, Alabama, Mississippi, Louisiana, Tennessee, Arkansas, Texas, Oklahoma, New Mexico, Colorado -- plus the territories of Puerto Rico and the US Virgin Islands. Under federal law, RACs review claims for compliance with CMS reimbursement policies, and identify both underpayments and overpayments. According to CMS, the RAC Program will rollout nationwide by January 1, 2010.

Connolly will use all of the annually updated, evidence-based Care Guidelines products -- Ambulatory Care, Inpatient and Surgical Care, General Recovery Guidelines, Recovery Facility Care, Home Care, Chronic Care Guidelines, and Behavioral Health Guidelines. CMS does not mandate or endorse the use of any specific screening product for medical reviews.

"The breadth and detail of the Care Guidelines enable informed and consistent clinical decisions for the best possible care throughout the entire care continuum," said Scott Harris, Milliman Care Guidelines Senior Vice President of Sales and Marketing. "Having access to our evidence-based clinical tools enables quality and audit organizations to effectively manage their review processes and initiatives to improve the care provided for Medicare beneficiaries."

The Care Guidelines promote healthcare quality by providing clinical guidelines based on the best available clinical evidence. The Care Guide
'/>"/>

SOURCE Milliman Care Guidelines
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chocolate Milks Natural Muscle Recovery Benefits Match or May Even Surpass a Specially Designed Carbohydrate Sports Drink
2. RecoveryPlanner and RiskWatch Partner to Deliver an Integrated Business Continuity-Risk Management Software Solution
3. HIV prevention program gets a boost from NIMH recovery act funds
4. Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts
5. Reducing Chronic Diseases Critical to Economic Recovery and Health Reform
6. Scorpion Anti-Venom Speeds Childrens Recovery
7. Enormous Recovery Challenges Remain in Myanmar One Year After Cyclone Nargis
8. SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense
9. Attorney General Eric Holder Honors Florida Doctor and Announces $4.7 Million in Recovery Act Funds for State
10. Looking Forward: Health Information Technology and the American Recovery and Reinvestment Act
11. Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Newswire/--XiotechCorporationtodayannouncedthatMas...000storagesystem,poweredbyIntelligentStorageElemen...eneeds,enablefuturegrowthanddeliversignificantcapi...r. ,, MasonGeneral,locatedinShelton,Wash.,wasra...ostWired-Rural"hospitalsin2008and2009foritssuperio...
(Date:11/23/2009)...e/--Thanksgivingweekendmarksthe36thannualStateFarm...representsthesportsmanshipandprideoftwoschoolsbuti...seinattendance. ,, ForthecrewofthenewU.S.CoastG...beforetheyworktotestandlaunchabrandnewshiptoprotec...yOfficerClaudeBovellandtherestofthecrewwillbeginte...
(Date:11/23/2009)...g flaxseed oil to the diet could reduce the risk o...with diabetes, according to a report to be publish...utrition and Public Health . , Mer Harvi and col... Egypt, have studied the effect of diabetes on bon...t might delay the onset of osteoporosis. The resea...
(Date:11/23/2009)...ly modified to produce bacterial proteins that are...ve been planted on more than 200 million hectares ... after the bacterium Bacillus thuringiensis , com...lowing farmers to save money and lessen environmen...wever, since insects can evolve resistance to toxi...
(Date:11/23/2009)...prove patient outcomes, research suggests , ...mbination drug therapy shows promise in treating p...rchers say. , The study from the Massachusetts ...t survival and tumor response in patients treated ...tor that has helped slow the growth of other cance...
Breaking Medicine News(10 mins):Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
...cks colorectal cancer in mice , Non-steroidal an...d ibuprofen, and drugs that selectively target a p...ntestinal polyps, the precursors of colorectal can...ers, at Vanderbilt University School of Medicine, ...
...ct Judge Edward R. Korman ordered the FDA to make ...nor girls without a physician,s visit or prescript...so asked the FDA to consider making the drug avail...Council , s Senior Fellow for Regulatory Affairs, ...
...ream Flights Plus Card™ Sales to be Donated ... Opportunity to Receive Special Privileges and Ser...eatment for Pediatric Patients , ...Hospital. Through the use of the Dream Flights Plu...
...erve as Non-Executive Chairman of the Board - , ,...aq: GPRO ) announced today that its board of dir...chief executive officer (CEO), effective May 18, 2...fficer, will become president and CEO following th...
...maceuticals (Nasdaq: ENDP ) today announced the ...s Pharmaceuticals, Inc. Endo acquired Indevus thr...ch Indevus became a wholly owned subsidiary of End...are in cash and up to an additional $3.00 per shar...
...ince 1995 Targets Burgeoning German Demand for Hea...f., March 23 VeriFone Holdings, Inc. (NYSE: PAY...et growing demand in Germany for electronic health...of experience to meet the needs of healthcare orga...
Other Medicine News:Health News:JCI table of contents: March 23, 2009 2Health News:JCI table of contents: March 23, 2009 3Health News:JCI table of contents: March 23, 2009 4Health News:JCI table of contents: March 23, 2009 5Health News:JCI table of contents: March 23, 2009 6Health News:JCI table of contents: March 23, 2009 7Health News:JCI table of contents: March 23, 2009 8Health News:JCI table of contents: March 23, 2009 9Health News:Dream Flights Luxury Travel, Inc. and St. Jude Children's Research Hospital Join Forces to Find Cures and Save Children 2Health News:Dream Flights Luxury Travel, Inc. and St. Jude Children's Research Hospital Join Forces to Find Cures and Save Children 3Health News:Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer 2Health News:Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer 3Health News:Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals 2Health News:VeriFone eHealth Initiative Extends German Market Presence 2Health News:VeriFone eHealth Initiative Extends German Market Presence 3
(Date:11/23/2009)...O,Calif.,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc...r.DavidC.U,PrichardhaveagreedtojointheAnesivaboard...etweenAnesivaandArcionTherapeutics.Completionofthe...aceatthepreviouslyannouncedAnesiva2009AnnualMeetin...PSTat400OysterPoint,Suite107A,SouthSanFrancisco,Ca...
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--RaptorPharmaceuticalCo...nouncedresultsfromaPhase2bclinicaltrialofitspropri...mine")inpatientswithnephropathiccystinosis("cystin...ia,SanDiego("UCSD")GeneralClinicalResearchCenter,e...rmacodynamicsofasingledoseofDRCysteamineinninecyst...
(Date:11/23/2009)...AZER,Pa.,Nov.23/PRNewswire-FirstCall/--CeptionTher...ny,andCephalon,Inc.(Nasdaq: CEPH )todayannouncedre...reslizumab)asatreatmentforpediatriceosinophiliceso...mentintheco-primaryendpointsofchangesinesophageale...taindicatedthatpatientstreatedwithCINQUILshowedast...
Breaking Medicine Technology:Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4FDA Investigating Safety of Asthma Drug Xolair 51948 1FDA Investigating Safety of Asthma Drug Xolair 51948 2Does Your Child Need Vision Therapy 3F 51946 1Does Your Child Need Vision Therapy 3F 51946 2Does Your Child Need Vision Therapy 3F 51946 3Does Your Child Need Vision Therapy 3F 51946 4Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 1Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 2Cogdell Spencer ERDMAN 28SM 29 Announces the Signing of Contracts Totaling 2488 8 Million in Janesville Wisconsin 51944 3
... Pharmaceutical,Research & Development, L.L.C. (J&...nstrate doripenem (DORIBAX(TM), doripenem for inje...ore potent in vitro against certain,strains of Ent...lactamases,(ESBLs) than other commonly used carbap...cteria that can cause,infections of the digestive ...
...ments in Productivity, Quality of Life and Lessen...can College of Rheumatology (ACR) Annual Sc... PST -- UCB announced,today results from several P...tolizumab pegol) - the only PEGylated anti-TNF (Tu...ollege of Rheumatology (ACR) Annual Scientific,Mee...
Other Medicine Technology:New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 2New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 3New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 4New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10
TME 61 C
TME 60 S
...for traditional Lasik, Epi-Lasik and anterior and ...f rapidly changing technologies and applications i... remains a proven value, offering surgeons a platf... stay abreast of evolving technologies while prote...
...maging device that provides direct cross sectional...d subjective clinical evaluation in the detection ...mages and analyzes macular thickness, the retinal ...est technology for high resolution scans., ,S...
Medicine Products: